Do you want to read an article? Please log in or register.
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis
Breast Cancer
Related content
Lung, Respiratory and Thoracic Cancer
Evaluating the safety of antibody-drug conjugates in lung cancer: A systematic review and meta-analysis
Lung Cancer
He Q, Jiang L, Xu Y, Wang M
doi: 10.1016/j.lungcan.2025.108425
Lung, Respiratory and Thoracic Cancer
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysis
Lung Cancer
Girard N, Han JY, Soo RA, Wang K, Tang W, Nikolaidis GF, Tasoulas A, Barouma I, Castro JC, Yang Z, Chaudhary T, Zhan L
doi: 10.1016/j.lungcan.2025.108450
RECOMMENDED
Breast Cancer
Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Cancer Treat Rev
Nakatani S, Hayashi T, Yamamoto K, Maeda H
doi: 10.1016/j.ctrv.2025.102923
Further Publications
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysis
Lung Cancer
Shao T, Yang J, Chen J, Zhang Y, Shou L
doi: 10.1016/j.lungcan.2025.108559
Lung, Respiratory and Thoracic Cancer
Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis
Cancers (Basel)
Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N, Waser N, Lee JM, Spicer J
doi: 10.3390/cancers16132492
Lung, Respiratory and Thoracic Cancer
Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
Lung Cancer
Pan Y, Gu Q
doi: 10.1016/j.lungcan.2025.108532
Genitourinary Cancer
Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis
Prostate Cancer Prostatic Dis
Matsukawa A, Yanagisawa T, Parizi MK, Laukhtina E, Klemm J, Fazekas T, Mori K, Kimura S, Briganti A, Ploussard G, Karakiewicz PI, Miki J, Kimura T, Rajwa P, Shariat SF
doi: 10.1038/s41391-024-00886-0
Lung, Respiratory and Thoracic Cancer
Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysis
Eur J Cancer
Acker F, Reck M, Martin D, Rieken S, Heinzen S, Rost M, Aguinarte L, Schulte H, Serve H, Oellerich T, Sebastian M, Althoff FC
doi: 10.1016/j.ejca.2025.115266
Breast Cancer
Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques
Breast Cancer Res Treat
Lee SF, Wong HCY, Robijns J, Ciocon SLB, Dos Reis PED, Sadeghi S, Al-Khaifi M, Ogita M, Chan AW, Rembielak A, Livesey D, Chong M, Liu ZA, Trombetta M, Koh WY, Leong YH, Marta GN, Bonomo P, Salvestrini V, Vassiliou V, Chopade P, Patel P, Wong C, Wolf JR, van den Hurk C, Chan RJ, Jefford M, Chow E, Kwan JYY, on behalf of the Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology and, Survivorship Study Groups
doi: 10.1007/s10549-025-07700-y